What's New in Musculoskeletal Oncology

被引:43
作者
Lewis, Valerae O.
机构
[1] M.D. Anderson Cancer Center, Houston, TX 77230-1402
关键词
SOFT-TISSUE SARCOMA; GIANT-CELL TUMOR; PROGNOSTIC-FACTORS; OSTEOSARCOMA; SURVIVAL; BONE; CHEMOTHERAPY; EXTREMITY; TRIAL; RECONSTRUCTION;
D O I
10.2106/JBJS.I.00375
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:1546 / 1556
页数:11
相关论文
共 50 条
  • [21] Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
    Nakamura, Tomoki
    Matsumine, Akihiko
    Yamada, Satoshi
    Tsukushi, Satoshi
    Kawanami, Katsuhisa
    Ohno, Takatoshi
    Katagiri, Hirohisa
    Sugiura, Hideshi
    Yamada, Kenji
    Yamada, Yoshihisa
    Sudo, Akihiro
    Nishida, Yoshihiro
    ONCOTARGETS AND THERAPY, 2016, 9 : 4747 - 4751
  • [22] What is New in Neuro-oncology?
    Thakkar, Jigisha P.
    Prabhu, Vikram C.
    Peters, Katherine B.
    Lukas, Rimas V.
    NEUROLOGIC CLINICS, 2021, 39 (01) : 163 - 179
  • [23] Children's Oncology Group's 2023 blueprint for research: Radiation oncology
    Kalapurakal, John A. L.
    Wolden, Suzanne L.
    Haas-Kogan, Daphne N.
    Laack, Nadia N.
    Hua, Chia-ho C.
    Paulino, Arnold C. E.
    Hill-Kayser, Christine E. S.
    Hoppe, Bradford S. J.
    Fitzgerald, Thomas J.
    COG Radiation Oncology Discipline Com
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [24] Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study
    Hirai, Toshihide
    Kobayashi, Hiroshi
    Kobayashi, Eisuke
    Saito, Masanori
    Akiyama, Toru
    Kikuta, Kazutaka
    Nakai, Takaaki
    Endo, Makoto
    Tsukamoto, Shinji
    Hakozaki, Michiyuki
    Takenaka, Satoshi
    Nishimura, Shunji
    Kawashima, Hiroyuki
    Tanzawa, Yoshikazu
    Kawano, Hirotaka
    Tanaka, Sakae
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (11) : 1758 - 1766
  • [25] Model-Based Drug Development in Oncology: What's Next?
    Bruno, R.
    Mercier, F.
    Claret, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (04) : 303 - 305
  • [26] Navigation in musculoskeletal oncology: An overview
    Morris, Guy Vernon
    Stevenson, Jonathan D.
    Evans, Scott
    Parry, Michael C.
    Jeys, Lee
    INDIAN JOURNAL OF ORTHOPAEDICS, 2018, 52 (01) : 22 - 30
  • [27] What's new in the treatment of seminomas?
    Boujelbene, N.
    Ozsahin, M.
    Khanfir, K.
    Azria, D.
    Mirimanoff, R. O.
    Zouhair, A.
    CANCER RADIOTHERAPIE, 2011, 15 (03): : 208 - 220
  • [28] New Developments in Neuro-Oncology
    Schlegel, U.
    AKTUELLE NEUROLOGIE, 2010, 37 (08) : 388 - 393
  • [29] The evolving role of computer-assisted navigation in musculoskeletal oncology
    Young, P. S.
    Bell, S. W.
    Mahendra, A.
    BONE & JOINT JOURNAL, 2015, 97B (02) : 258 - 264
  • [30] Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force
    Whittle, Sarah B.
    Offer, Katharine
    Roberts, Ryan D.
    LeBlanc, Amy
    London, Cheryl
    Majzner, Robbie G.
    Huang, Alex Y.
    Houghton, Peter
    Alejandro Sweet Cordero, E.
    Grohar, Patrick J.
    Isakoff, Michael
    Bishop, Michael W.
    Stewart, Elizabeth
    Slotkin, Emily K.
    Greengard, Emily
    Borinstein, Scott C.
    Navid, Fariba
    Gorlick, Richard
    Janeway, Katherine A.
    Reed, Damon R.
    Hingorani, Pooja
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)